Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) EPS (Weighted Average and Diluted) (2016 - 2025)

Orthofix Medical's EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at -$0.05 for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 93.33% year-over-year to -$0.05, compared with a TTM value of -$2.33 through Dec 2025, up 29.18%, and an annual FY2025 reading of -$2.33, up 29.39% over the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.05 at Orthofix Medical, up from -$0.57 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.12 in Q2 2021, with the low at -$1.71 in Q1 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.62, with a median of -$0.58 recorded in 2025.
  • Year-over-year, EPS (Weighted Average and Diluted) surged 112.5% in 2021 and then crashed 991.67% in 2023.
  • Tracing OFIX's EPS (Weighted Average and Diluted) over 5 years: stood at -$1.67 in 2021, then skyrocketed by 79.04% to -$0.35 in 2022, then plummeted by 68.57% to -$0.59 in 2023, then decreased by 27.12% to -$0.75 in 2024, then surged by 93.33% to -$0.05 in 2025.
  • Per Business Quant, the three most recent readings for OFIX's EPS (Weighted Average and Diluted) are -$0.05 (Q4 2025), -$0.57 (Q3 2025), and -$0.36 (Q2 2025).